Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FlutiForm in moderate to severe asthma (SKY2028-3-006)
NCT00747318Phase 3Completed
- Sponsor
- Skyepharma
- Start
- Sep 2008
- Primary completion
- May 2010
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of fluticasone propionate + formoterol in asthma, sponsored by Skyepharma. Started Sep 2008; status: completed.
02
Drugs
fluticasone propionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00747318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00747318.